Goldman Sachs’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-30,622
| Closed | -$307K | – | 5470 |
|
|
2022
Q3 | $307K | Sell |
30,622
-25,000
| -45% | -$251K | ﹤0.01% | 4540 |
|
|
2022
Q2 | $550K | Sell |
55,622
-498,000
| -90% | -$4.92M | ﹤0.01% | 4315 |
|
|
2022
Q1 | $5.45M | Buy |
553,622
+518,510
| +1,477% | +$5.1M | ﹤0.01% | 2732 |
|
|
2021
Q4 | $343K | Sell |
35,112
-2,090
| -6% | -$20.4K | ﹤0.01% | 4717 |
|
|
2021
Q3 | $364K | Buy |
37,202
+26,103
| +235% | +$255K | ﹤0.01% | 4558 |
|
|
2021
Q2 | $109K | Buy |
+11,099
| New | +$109K | ﹤0.01% | 5100 |
|